MagStents · Magnetically Actuated Stents: Enhancing Precision and Control in Vascular Interventions using Superparamagnetic Hydrogels Composites
„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“
- Период
- 2025-09-01 → 2027-08-31
- Финансиране от ЕС
- 207 758 €
- Участници
- 1
- Схема
- HORIZON-TMA-MSCA-PF-EF
Линиите свързват координатора с партньорите.
Накратко на български
Магнитни хидрогели се използват за създаване на гъвкави стентове, които могат да се управляват дистанционно чрез външни магнитни полета. Това помага за по-прецизно разгръщане в кръвоносните съдове и подобрява контрола върху лечението при сърдечно-съдови заболявания.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Magnetically Actuated Stents: Enhancing Precision and Control in Vascular Interventions using Superparamagnetic Hydrogels Composites
Cardiovascular diseases remain one of the leading causes of death worldwide and place a major burden on healthcare systems. Millions of patients each year require vascular interventions involving stents to restore blood flow in narrowed or blocked blood vessels. Despite their widespread use, conventional metallic stents remain passive devices that cannot be actively controlled after implantation. They also face persistent challenges including restenosis, limited adaptability to complex vascular geometries, and restricted capability for localized therapeutic intervention. Recent advances in soft materials, magnetic nanotechnology, and microfabrication have created opportunities to develop next-generation biomedical devices that are more responsive, adaptable, and patient-specific. However, significant scientific barriers remain. Existing magnetic soft robotic systems often suffer from limited mechanical robustness, insufficient magnetic responsiveness, poor reproducibility of magnetic materials, and a lack of scalable design methodologies that connect material properties with device performance. The MagStents project was established to address these challenges through the development of magnetically responsive soft stent technologies based on engineered magnetic nanomaterials, magnetic hydrogels, and auxetic architectures. The project aimed to create an integrated design platform capable of combining magnetic actuation, soft-material mechanics, and advanced microfabrication into a single biomedical device concept. Particular emphasis was placed on achieving precise remote actuation through externally applied magnetic fields while maintaining the flexibility and compliance required for minimally invasive vascular applications. The project pathway to impact was based on three sequential stages. First, a reproducible library of ferrite magnetic nanoparticles with tunable magnetic properties was developed to provide controlled magnetic torque generation. Second, these nanoparticles were incorporated into dual-crosslinked magnetic hydrogels to create mechanically stable and magnetically responsive materials suitable for biomedical actuation. Third, computational modelling and advanced microfabrication approaches were employed to design auxetic stent architectures capable of controlled deformation under magnetic stimuli. During the reporting period, the project successfully established the materials platform and design framework required for future magnetically actuated stent systems. Although the fellowship ended before biofluid testing and drug-release studies could begin, the completed work generated critical scientific knowledge, validated materials technologies, and fabrication methodologies that significantly advance the development of remotely controllable soft biomedical devices. The results provide a technological foundation for future vascular implants, soft robotic medical devices, and magnetically controlled therapeutic platforms that could ultimately contribute to safer, less invasive, and more personalized healthcare solutions.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Cardiovascular diseases represent a critical global health challenge, affecting millions through the obstruction of blood vessels. Existing interventions, particularly conventional stents, are hindered by significant limitations such as rigidity and a high risk of restenosis. This proposal introduces MagStents, an innovative fusion of soft polymers and magnetic nanoparticles, designed to overcome these challenges. While traditional metal stents restore blood flow, they are constrained by inflexibility and potential vessel damage. In contrast, MagStents offer a biocompatible, flexible, and self-expanding alternative, constructed from dual crosslinked hydrogels.A key advancement of MagStents is their magnetic actuation, enabling precise positioning, adjustment, and post-deployment control using an external magnetic field. This capability introduces a novel dimension in cardiovascular intervention, reducing the need for surgical procedures by allowing real-time non-invasive adjustments.The research will focus on the development of Magnetic hydrogels (MagGels), engineered with controlled magnetic and mechanical properties. Advanced additive manufacturing technique will be employed to fabricate MagStents that incorporate these MagGels, ensuring both structural integrity and magnetic responsiveness. Comprehensive evaluations will assess biocompatibility, mechanical performance, and magnetic behavior, alongside the potential for controlled drug release in vitro.MagStents offer a significant advancement in interventional cardiology by enabling remote, non-invasive manipulation and enhanced adaptability. The research aims to establish a new standard for stent performance, improving patient outcomes and addressing the current limitations of cardiovascular disease treatments. Through their unique combination of magnetic control and biocompatibility, MagStents hold the potential to revolutionize stent technology and patient care.
Оригинален текст от CORDIS (на английски).
Участници
- VYSOKE UCENI TECHNICKE V BRNE · BRNO STREDКоординаторЧехия
Връзки
- Виж в CORDIS
- DOI: 10.3030/101204982
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e52a091f8b&appId=PPGMS
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e52e21cb3e&appId=PPGMS
Данни: CORDIS, © Европейски съюз
